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Classical cadherins accumulate at cell–cell contacts as a characteristic response to productive adhesive ligation. Such local
accumulation of cadherins is a developmentally regulated process that supports cell adhesiveness and cell–cell cohesion.
Yet the molecular effectors responsible for cadherin accumulation remain incompletely understood. We now report that
Myosin 2 is critical for cells to concentrate E-cadherin at cell–cell contacts. Myosin 2 is found at cadherin-based cell–cell
contacts and its recruitment requires E-cadherin activity. Indeed, both Myosin 2 recruitment and its activation were
stimulated by E-cadherin homophilic ligation alone. Inhibition of Myosin 2 activity by blebbistatin or ML-7 rapidly
impaired the ability of cells to concentrate E-cadherin at adhesive contacts, accompanied by decreased cadherin-based cell
adhesiveness. The total surface expression of cadherins was unaffected, suggesting that Myosin 2 principally regulates the
regional distribution of cadherins at the cell surface. The recruitment of Myosin 2 to cadherin contacts, and its activation,
required Rho kinase; furthermore, inhibition of Rho kinase signaling effectively phenocopied the effects of Myosin 2
inhibition. We propose that Myosin 2 is a key effector of Rho-Rho kinase signaling that regulates cell–cell adhesion by
determining the ability of cells to concentrate cadherins at contacts in response to homophilic ligation.
INTRODUCTION
Simple things are sometimes surprisingly complex. This is
exemplified by the relationship between cadherin adhesion
and cell–cell contacts. Classical cadherins accumulate and
concentrate at contacts between cells in many solid tissues of
the body (Takeichi, 1991). At those contacts cadherins me-
diate cell–cell recognition, organize cells into coherent
sheets and populations, and modulate morphogenetic pro-
cesses such as polarity and locomotion. The ability of cells to
concentrate their cadherins at contacts likely supports adhe-
sive strengthening, stabilizes the cohesiveness of contacts
and is commonly thought to be necessary for the assembly
of adherens junctions. Consistent with its morphogenetic
potential, such local concentration of E-cadherin within cell–
cell contacts is a developmentally regulated event in the
early mouse embryo that coincides with compaction (Vest-
weber et al., 1987). Despite this, the molecular and cellular
mechanisms responsible for concentrating cadherins at con-
tacts remain incompletely understood.
Cadherins function as membrane-spanning macromolec-
ular complexes (Takeichi, 1991) and cooperation between
cadherin ectodomains and cytoplasmic elements appears
necessary to concentrate cadherins at contacts. The neces-
sary requirement for a functional ectodomain was first sug-
gested by the observation that cadherin mutants lacking a
functional ectodomain distributed diffusely when expressed
on the surfaces of cadherin-deficient fibroblasts (Fujimori
and Takeichi, 1993). Subsequent biochemical and structural
studies of cadherin ectodomains raised the possibility that
protein-protein interactions within this region itself might
themselves support oligomerization. The cadherin ectodo-
main can engage in both lateral (cis) interactions as well as in
homophilic (trans) interactions. It was postulated that the
combination of these cis- and trans-interactions might cause
cadherins to coassemble into zipperlike arrays (Shapiro et al.,
1995) or more complex three-dimensional structures (Gum-
biner, 1996), resulting in their local concentration. However,
it is also commonly observed that cadherin mutants lacking
their cytoplasmic tails fail to accumulate in cell–cell contacts
(Fujimori and Takeichi, 1993), despite retaining demonstra-
ble homophilic binding activity and being expressed at the
cell surface (Brieher et al., 1996; Yap et al., 1997). This indi-
cates that, whatever the contribution(s) of the ectodomain
(Boggon et al., 2002), cytoplasmic interactions are also nec-
essary to concentrate cadherins at cell–cell contacts.
Key cytoplasmic contributions appear to involve interac-
tions between cadherins, cell signaling pathways, and the
actin-based cytoskeleton. Notably, members of the Rho fam-
ily of small GTPases can exert significant effects on cadherin
accumulation. Disruption of Rho signaling, in particular,
caused E-cadherin to be rapidly lost from epithelial cell–cell
contacts before the cohesive interactions between cells were
disrupted (Braga et al., 1997, 2000; Takaishi et al., 1997;
Charrasse et al., 2002). Furthermore, effectors of Rho signal-
ing, including mDia and Rho kinase were found to support
the integrity of cadherin-based cell contacts in some (Vaezi et
al., 2002) studies, but not in all instances (Sahai and Mar-
shall, 2002). Similarly, the integrity of the actin cytoskeleton
is necessary for cadherin adhesion and cadherin mutants
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that cannot interact with -catenin, the best-understood
mechanism that binds cadherins to cortical actin, often fail to
accumulate at cell–cell contacts (Sako et al., 1998). Given that
Rho GTPases are fundamental regulators of the actin cy-
toskeleton, it is attractive to postulate that Rho may support
local cadherin concentration through an impact on cadherin-
actin interactions. However, it is becoming increasingly ap-
parent that multiple dynamic forms of actin activity occur at
cadherin adhesive contacts, accompanied by a range of actin
regulators and actin-based effector molecules (Kovacs et al.,
2002b; Vaezi et al., 2002). The precise targets of Rho that
might support local cadherin accumulation, though, remain
to be identified.
In the current report, we focused on the potential for
Myosin 2 to regulate local cadherin accumulation at cell–cell
contacts. Myosin 2 is a well-characterized target of Rho
signaling that has been reported to localize to epithelial
cell–cell junctions (Bertet et al., 2004; Conti et al., 2004; Zallen
and Wieschaus, 2004) as well as to perijunctional actin cables
(Krendel et al., 1999). Myosin 2 activity is implicated in
remodelling cadherin-based cell–cell contacts during planar
cell intercalation in Drosophila embryos (Bertet et al., 2004)
and potentially also in cultured mammalian cells (Krendel et
al., 1999). Strikingly, mouse embryos deficient in the Myosin
2A isoform, and embryoid bodies derived from such em-
bryos, display decreased cell–cell cohesion and reduced
E-cadherin staining at cell–cell contacts (Conti et al., 2004).
We now report that homophilic cadherin ligation is suffi-
cient to recruit Myosin 2 to cadherin adhesive contacts in a
Rho-kinase-dependent manner, where it is necessary to sup-
port the local concentration of E-cadherin and the integrity
of adherens junctions.
MATERIALS AND METHODS
Cell Culture, Transfections, and Adhesion Assays
MCF-7 and Chinese hamster ovary (CHO) cells stably transfected with human
E-cadherin (hE-CHO) have been described previously (Kovacs et al., 2002a;
Paterson et al., 2003). Cells were transfected using either Lipofectamine Plus
Reagent or Lipofectamine 2000 according to manufacturer’s instructions and
analyzed 24–72 h after transfection. hE/Fc was prepared and used as previ-
ously described (Kovacs et al., 2002a).
Homophilic adhesion to hE/Fc-coated substrata was measured by resis-
tance to detachment as previously described (Verma et al., 2004). In brief,
nitrocellulose-coated six-well plates were incubated with hE/Fc (in Hanks’
balanced salt solution [HBSS], containing 5 mM CaCl2) overnight at 4°C and
then blocked with bovine serum albumin (10 mg/ml, 2 h at 4°C). Cells were
isolated by incubation for 10 min in 0.01% (wt/vol) crystalline trypsin (Sigma,
St. Louis, MO) in HBSS containing 5 mM CaCl2. Freshly isolated cells were
allowed to attach to substrata for 90 min at 37°C in a CO2 incubator and then
subjected to detachment by systematic pipetting. For this, five regions in each
well (the 4 quadrants and center) were washed twice with 200 l HBSS/CaCl2
delivered using a stand-mounted pipette. Cells remaining adherent to the
wells were then incubated with MTT (10 mg/ml) dissolved in dimethyl
sulfoxide and read at OD595 in a microplate reader. Cellular content in wells
after pipetting was compared with the cellular content of wells prepared
under identical conditions, but not subjected to pipetting (yielding the total
number of cells plated in each well).
Plasmids
pEGFP-NMHC-2A (nonmuscle Myosin 2A heavy chain; GFP-Myosin 2A) was
a kind gift from Dr. R. Adelstein (Wei and Adelstein, 2000). Human
E-cadherin tagged with YFP at its C-terminus was generated by PCR ampli-
fication of the coding sequence for hE-cadherin using primers that introduced
a 5-HindIII site and 3-SacII site. This was subsequently subcloned into
pEYFP-N1 (Clontech, Palo Alto, CA). CHO cells stably expressing hE-Cad-
YFP were made by Lipofectamine transfection and selection with G418.
Antibodies
Primary antibodies were as follows: 1) Mouse monoclonal antibody (mAb)
against the cytoplasmic domain of E-cadherin (Transduction Laboratories,
Lexington, KY); 2) mouse mAb HECD-1 against the ectodomain of human
E-cadherin (a kind gift from Dr. Peggy Wheelock with the permission of Dr.
M. Takeichi); 3) rabbit pAb for human nonmuscle Myosin 2A heavy chain
(Covance, Madison, WI); 4) rabbit pAb against GFP (Roche, Indianapolis, IN);
5) rabbit pAb raised against Thr18- and Ser19- phosphorylated MLC (ppMLC,
a kind gift of Dr. J. Staddon) (Ratcliffe et al., 1999); 6) mouse mAb SHE 78–7
against human E-cadherin (Zymed, Laboratories, South San Francisco, CA);
and 7) monoclonal anti--tubulin (Sigma). Species-specific secondary anti-
bodies conjugated to Alexa-488 or Alexa-594 were obtained from Molecular
Probes (Eugene, OR). F-actin was identified with TRITC-phalloidin.
Trypsin Protection Assay
The surface expression of E-cadherin was measured by sensitivity to surface
trypsinization as described previously (Verma et al., 2004). In brief, cells were
incubated with crystalline trypsin (0.05% wt/vol) in HBSS in the presence of
either 2 mM CaCl2 or 5 mM EDTA for 20 min at 37°C. Cells were collected and
lysed directly into Laemmli sample buffer. Equal volumes of the cellular
extracts were separated by SDS-PAGE followed by Western analysis with
antibodies specific for the ectodomain of E-cadherin (HECD-1) and -tubulin
(as a loading control).
Immunofluorescence Microscopy and Image Analysis
Where indicated, samples were briefly extracted with nonionic detergent
before fixation. Briefly, cells were transferred to ice for 3 min, incubated with
prepermeabilization buffer (0.5% TX-100, 10 mM Pipes pH 6.8, 50 mM NaCl,
3 mM MgCl2, 300 mM sucrose containing 1 Complete protease inhibitors
[Roche]) for 10 min followed by fixation with paraformaldehyde (4% PFA in
CSK) for 20 min at room temperature.
Epi-illumination fluorescence microscopy of fixed specimens was per-
formed using IX81 microscopes fitted with 100, 1.40 NA objectives. Images
were acquired with Hamamatsu Orca-1 ER cameras (Bridgewater, NJ) driven
by Metamorph imaging software (Version 6.2, Universal Imaging, West Ches-
ter, PA). Background correction and contrast manipulation of raw data im-
ages were performed in either ImageJ (version 1.30; NIH) or Adobe Photo-
shop (version 7; San Jose, CA). Z-stacks of epifluorescence images were
deconvolved using the Autoquant Blind 3D deconvolution program (Auto-
Quant Imaging, Watervliet, NY).
The intensity of E-cadherin fluorescence at cell contacts was measured
using the line scan function in Metamorph (Universal Imaging). A total of 50
lines, 120–160 pixels in length, were drawn through each junction, and the
average pixel intensity for each position along the line was determined. A
minimum of 20 junctions were analyzed per experiment, and the area under
the curves was determined using Prism (v3.0; Graph Pad, Sorrento, CA) and
Microsoft Excel (Redmond, WA). Experiments were performed three times.
To quantitate cell extension on hE/Fc-coated substrata (Helwani et al., 2004),
the outer margins of broad cadherin-based lamellipodia were identified by
phalloidin staining. For each cell the lengths of each outer margin were
measured and summed, and the total length of the outer margins expressed
as a percentage of the perimeter of that cell (Lamellipodial index [LI]).
Live Cell Imaging
E-Cad-YFP cells were plated onto 25-mm round coverslips (Lomb Scientific
and Co., Taren Point, Australia) and housed throughout the course of movie
capture in a custom-built water-jacketed chamber maintained at 37.4°C. Cells
were incubated in phenol red-free HBSS/Ca containing 0.05% fetal calf se-
rum, buffered with 10 mM HEPES (pH 7.4). Epifluorescent live cell imaging
was performed using an Olympus IX81 equipped with 60X and 100X PLAN-
Apo (NA 1.4) objectives (Lake Success, NY). Images were captured with a
Hamamatsu Orca1-ER camera driven by Metamorph software. For live cell
imaging of blebbistatin-treated cells, images of cells were taken immediately
before, and 1 h after, addition of blebbistatin (10 M) using identical expo-
sures (600 ms) and camera acquisition settings. Intensity of E-cadherin-YFP at
cell–cell contacts was determined using the line-scan analysis function in
Metamorph (version 6.2), as described above.
Fluorescence recovery after photobleaching (FRAP) analysis utilizing the
aforementioned live cell imaging system has been previously reported (Hel-
wani et al., 2004). Briefly, junctions were identified under low light, and a
prebleach image was captured. Immediately afterward the iris field dia-
phragm was then closed to its minimum diameter and the light path was
cleared of filters, enabling exposure of the selected region of interest (ROI) to
maximal light from the mercury burner for no more than 25 s. FRAP time
series movies were then commenced, with images captured every 30 s for a
total of 20–25 min. Where inhibitors were used to assess their impact on
junctional E-cadherin accumulation, cells were pretreated for 60 min at 37°C
before transfer to the heated slide mount and incubated in media containing
the appropriate drug. FRAP analysis was performed in ImageJ as previously
described (Helwani et al., 2004). Raw data were normalized as detailed in
Rabut and Ellenberg (2005). Briefly, raw data were first adjusted by back-
ground subtraction at each time point, corrected to a time-matched ROI that
had not been photobleached, and then normalized to the background-sub-
tracted prebleach image. Kinetic modeling was performed in Prism, using the
equation detailed in Table 1.
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RESULTS
Myosin 2 Accumulates at Cell–Cell Junctions in an
E-Cadherin-dependent Manner
We began by comparing the cellular localization of Myosin
2 and E-cadherin in MCF-7 mammary epithelial monolayers
(Figure 1). Because similar results were obtained for both the
Myosin 2A and Myosin 2B isoforms, only data for Myosin
2A are shown here. Indirect immunofluorescence micros-
copy revealed that endogenous Myosin 2A distributed ex-
tensively throughout the cells, with prominent staining in
radial striations in the periphery of the cytoplasm (unpub-
lished data), as observed by others (Vaezi et al., 2002); this
radial pattern was characteristically found at the basal re-
gions of the cells. In addition, Myosin 2 also localized in the
immediate proximity of E-cadherin-enriched cell–cell con-
tacts, where it stained in puncta that overlapped with some,
but not all, areas of cadherin staining (Figure 1A). Preextrac-
tion of MCF-7 monolayers with nonionic detergents before
fixation substantially reduced the cytoplasmic pool of en-
dogenous Myosin 2A (unpublished data), revealing a resid-
ual pool found with E-cadherin at cell–cell contacts. Simi-
larly transiently expressed EGFP-Myosin 2A was clearly
visible at cadherin adhesions in preextracted samples
(Figure 1B). Together, these data suggested that a sub-
population of Myosin 2 can accumulate at cadherin-based
cell– cell contacts, both in the actin-rich perijunctional
regions of the contacts and at more limited sites within the
contacts themselves.
Furthermore, E-cadherin activity was necessary for Myo-
sin 2 to accumulate at cell–cell contacts. Incubation of
MCF-7 monolayers with the function-blocking anti-E-cad-
herin antibody SHE 78–7 (Kovacs et al., 2002b) caused much
Myosin 2 staining to be lost from cell–cell contacts within
15–30 min, when E-cadherin remained still detectable at the
contacts (Figure 1C). Longer exposure to blocking antibodies
caused cadherin to be lost from contacts and eventually
disrupted the cohesiveness of the contacts themselves.
E-Cadherin Homophilic Ligation Is Sufficient to Recruit
and Activate Myosin 2A
To extend these observations, we then asked whether
E-cadherin homophilic adhesion might be capable of recruit-
ing Myosin 2A to the cell cortex, using a recombinant cad-
herin ligand (hE/Fc), consisting of the complete ectodomain
of human E-cadherin fused to the Fc region of IgG (Kovacs
et al., 2002a, 2002b). When adsorbed on latex beads, hE/Fc
and similar cadherin ligands (Brieher et al., 1996; Lambert et






of recovery (min1) t1/2 (min)
Control 64.84  4.7 0.069 0.009 10.8 1.8
ML-7 (10 M) 35.6  4.1b 0.013  0.002b 57.0  8.7b
Y27632 (10 M) 32.4  6.9c 0.014  0.006b 42.5  9.6c
Contacts between cells expressing YFP-tagged E-cadherin were
photobleached and fluorescence recovery monitored as described in
Materials and Methods. Raw data were corrected to account for
background fluorescence, photobleaching effects, and burner fluc-
tuations over time and then normalized to the prebleach image.
Kinetic modeling of recovery data was performed in Prism using
the equation: Y(t)  (Ymax  Ymin)(1  e(k.t))  Ymin.
a Percent recovery was determined by calculating the proportion of
bleached fluorescence that was recovered within the 24-min post-
bleaching observation period.
Experiments were performed at least five times, and data are pre-
sented as mean  SEM. Significance of data were determined by
Student’s t test; b p  0.005; and c p  0.02 compared with controls.
Figure 1. Myosin 2 accumulates at cell–cell contacts in an
E-cadherin-dependent manner. (A) Endogenous Myosin 2A local-
izes in puncta at cadherin-based cell–cell contacts. Confluent MCF-7
monolayers were fixed and labeled with antibodies specific for
E-cadherin and Myosin 2A. (B) Exogenous GFP-tagged Myosin 2A
also localizes in regions within E-cadherin-based cell–cell contacts.
MCF-7 cells were transiently transfected with EGFP-tagged Myosin
2A, briefly extracted with TX-100 before fixation and costained both
for E-cadherin and the GFP epitope tag (GFP-Myosin 2A). A single
image plane is shown after 3D deconvolution. (C) E-cadherin is
necessary for Myosin 2A localization at cell–cell contacts. Confluent
MCF-7 cell monolayers were incubated in medium alone (No anti-
body) or in the presence of the E-cadherin function-blocking
SHE78–7 mAb (1:50) for 15 min. E-cadherin was detected using the
prebound blocking antibody, whereas Myosin 2A was detected
using isoform-specific antibodies. Exposure to SHE78–7 substan-
tially reduced and reorganized Myosin 2A staining at contacts that
still retained E-cadherin.
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al., 2002; Niessen and Gumbiner, 2002) can bind to the dorsal
surfaces of E-cadherin-expressing cells, thereby presenting
spatially confined adhesive platforms that recruit a range of
actin-regulatory and signaling molecules, without detectable
integrin activation (Yap et al., 1997; Kovacs et al., 2002a). As
reported previously, binding of hE/Fc-coated beads is suf-
ficient to induce the E-cadherin molecular complex (as
marked by staining for -catenin) to accumulate at sites of
adhesion, where it characteristically stained as a “flare” in
the vicinity of the bead (Figure 2A, arrowheads). No com-
parable -catenin accumulation was observed where cells
bound to latex beads coated with the nonspecific ligand,
concanavalin A (ConA). Marked recruitment of EGFP-My-
osin 2A was observed at sites where E-cadherin-expressing
cells bound to hE/Fc-coated beads, compared with ConA
controls (Figure 2A). This suggested strongly that cadherin
homophilic ligation was sufficient to recruit Myosin 2 into
adhesive contacts.
Myosin 2 is activated by phosphorylation of the regula-
tory myosin light chain (MLC), an event that responds to
both myosin light chain kinase (MLCK) and Rho kinase
signaling (Bresnick, 1999; Ueda et al., 2002). Phosphorylated
MLC (ppMLC) was detectable at cell–cell contacts by im-
munofluorescence (see Figure 6B), whereas Myosin 2A re-
cruitment to sites of hE/Fc-induced adhesion was largely
abolished in cells treated with either Y-27632 or ML-7 (Fig-
ure 2A), inhibitors of Rho kinase and MLCK, respectively.
This suggested that activation of Myosin 2 was necessary for
its recruitment by cadherin adhesion.
We then used activation-specific ppMLC antibodies (Rat-
cliffe et al., 1999) to test whether cadherin homophilic liga-
tion could stimulate Myosin 2 activity. Freshly isolated
MCF-7 cells were allowed to adhere for 90 min to substrata
coated with either hE/Fc or poly-l-lysine (PLL), before lysis
and separation of polypeptides by SDS-PAGE. As shown in
Figure 2B, conspicuously higher levels of activated ppMLC
were detected in cells adherent to hE/Fc compared with
those attached to PLL, indicating that cadherin homophilic
adhesion could activate Myosin 2. MLC phosphorylation
upon adhesion to hE/Fc was reduced in cells treated with
either Y-27632 or ML-7. Although at the concentrations used
ML-7 did not reduce ppMLC levels to the same extent as
Y-27632, it substantially reduced the amount of Myosin 2
detectable at cell–cell contacts (Supplementary Figure 1),
indicating that ML-7 could effectively perturb Myosin 2
activity in cells. In contrast, stimulation of Myosin 2 phos-
phorylation was not affected by blebbistatin, a specific in-
hibitor of Myosin 2 ATPase activity (Straight et al., 2003) that
does not directly affect the phosphorylation status of MLC.
Taken together, these findings indicate that E-cadherin ho-
mophilic ligation is sufficient to recruit and activate Myosin
2, processes which involve both MLCK and Rho kinase
signaling.
Inhibition of Myosin 2 Motor Activity Perturbs the Local
Concentration of E-Cadherin at Cell–Cell Contacts
To assess the functional impact of Myosin 2, we first directly
inhibited Myosin 2 motor activity with blebbistatin (Figure
3). Strikingly, blebbistatin (100 M) rapidly altered the im-
munofluorescent staining of E-cadherin in confluent MCF-7
monolayers. Instead of accumulating in the characteristic
intense circumferential “chicken-wire” pattern seen in the
apical regions of control cultures (Figure 3A), E-cadherin
staining in the apical regions of drug-treated cells appeared
less intense and concentrated, often being interrupted by
discontinuities (Figure 3A). In addition, E-cadherin staining
in blebbistatin-treated cells often extended away from the
apical contacts, in what appeared to represent overlapping
cell–cell contacts (Figure 3A, arrow). Quantitation revealed
that blebbistatin reduced the fluorescence intensity of
E-cadherin staining at cell–cell contacts by 50% within 60
min of treatment, a reduction that persisted for several hours
(Figure 3A). However, neither the total cellular level of
E-cadherin, nor the amount expressed at the cell surface
measured using surface trypsin sensitivity assays, were af-
fected by blebbistatin (Figure 3B). This indicated that inhi-
bition of Myosin 2 initially caused E-cadherin to redistribute
on the surface away from cell–cell contacts.
Figure 2. E-cadherin homophilic ligation is sufficient to recruit and
activate Myosin 2A. (A) E-cadherin homophilic ligation triggers the
recruitment of Myosin 2A to sites of adhesion. Latex beads coated
with either hE/Fc or ConA were allowed to adhere for 90 min to the
dorsal surface of hE-CHO cells transiently expressing GFP-tagged
Myosin 2A (GFP-Myosin 2A). Cells were then immunolabeled with
antibodies specific for GFP and -catenin (marking the cadherin-
catenin complex). Both GFP-Myosin 2A and the cadherin complex
show significantly greater accumulation in flares around the hE/
Fc-beads (arrowheads) when compared with ConA-coated control
beads. Incubation with either Y-27632 (10 M) or ML-7 (10 M)
markedly reduced the recruitment of GFP-Myosin 2A to cadherin
homophilic adhesions. (B) E-cadherin homophilic ligation activates
Myosin 2. Cells were allowed to adhere to dishes coated with either
poly-l-lysine (PLL) or hE/Fc in the presence of blebbistatin (Blebbi,
10 M), Y-27632 (10 M), or ML-7 (10 M) for 90 min. Western blots
from cell lysates were probed for di-phosphorylated, activated my-
osin light chain (ppMLC) or -tubulin (as a loading control).
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As a further test of this notion, we used live cell imaging
to test how blebbistatin affected cadherin accumulation at
contacts between CHO cells stably expressing E-cadherin
tagged with YFP at its C-terminus (hE-Cad-YFP-CHO cells;
Figure 4). Like other GFP-tagged cadherins (Adams et al.,
1998), E-Cad-YFP was efficiently expressed at the surface of
CHO cells, typically accumulating in puncta at cell–cell
contacts (Figure 4). E-Cad-YFP also associated with catenins
and conferred cadherin-specific adhesion on these cells that
otherwise lack significant levels of endogenous classical cad-
herins (unpublished data). Because visible light is reported
to have complex interactions with blebbistatin (Kolega, 2004;
Sakamoto et al., 2005), we briefly imaged individual contacts
immediately before, and 60 min after, treatment with the
drug, thereby minimizing cellular exposure to light. E-Cad-
YFP puncta were less apparent and fluorescence intensity at
contacts was reduced to 58.25  4.7% of baseline in bleb-
bistatin-treated cells, whereas cadherin fluorescence was un-
changed in control cultures (Figure 4). E-Cad-YFP fluores-
cence was also reduced to a similar extent when multiple
different contacts were sampled before and after exposure to
blebbistatin (ensuring that no individual contact was im-
aged twice; unpublished data). Trypsin sensitivity assays
showed that E-Cad-YFP remained on the cell surface (un-
published data), indicating that the protein was redistribut-
ing to nonjunctional regions of the cell surface, consistent
with what we observed for endogenous E-cadherin in
MCF-7 cells (Figure 3). Taken together, these data indicate
that inhibition of Myosin 2 caused E-cadherin to be lost from
cell–cell contacts and redistribute to extrajunctional regions
of the cell surface.
Figure 3. Myosin 2 motor activity is necessary for the local con-
centration of E-cadherin at cell–cell contacts. (A) Blebbistatin per-
turbs E-cadherin accumulation in cell–cell contacts. MCF-7 cells
were treated with blebbistatin in complete growth media for vary-
ing periods of time and then fixed and processed for E-cadherin
immunofluorescence. Representative images of cells treated with
drug or control for 60 min are shown. Note that although vehicle-
treated cells showed continuous chicken-wire E-cadherin staining
(arrowheads), in drug-treated cells the apical cadherin staining was
less intense and often discontinuous (arrowhead), whereas E-cad-
herin staining also extended away in overlapping cell–cell contacts.
E-cadherin fluorescence intensity at cell–cell contacts (Junctional
E-cadherin) was measured by digital image analysis of drug-treated
and control cultures (data are means SE). (B) Inhibition of Myosin
2 does not affect the surface expression of E-cadherin. MCF-7 cells
were treated with blebbistatin (100 M) for 90 min before exposure
to crystalline trypsin for 20 min in the presence of either 2 mM CaCl2
(Ca) or 5 mM EGTA (E). Lysates from these cells and untreated cells
(SM, starting material) were subjected to SDS-PAGE and immuno-
blotted for E-cadherin and -tubulin (as a loading control).
Figure 4. Blebbistatin perturbs the accumulation of YFP-tagged
E-cadherin at cell–cell contacts. CHO cells stably expressing E-Cad-
YFP were examined by live-cell imaging. Individual contacts were
imaged (600-ms exposures) before, and 1 h after, addition of
blebbistatin (10 M) using identical camera acquisition settings.
Fluorescence intensity at contacts was determined as described in
Materials and Methods; fluorescence intensity after blebbistatin (E-
Cad-YFP accumulation) was expressed as a percentage of fluores-
cence intensity before the drug; n  10–14, p  0.001 (Student’s t
test). E-Cad-YFP accumulated in prominent puncta at cell–cell con-
tacts. Puncta were less prominent (arrows), and fluorescence inten-
sity at contacts reduced, after treatment with blebbistatin.
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Activation of Myosin 2 by MLCK Is Necessary for
E-Cadherin to Accumulate at Cell–Cell Contacts
We then asked whether inhibiting MLCK, the principal ki-
nase responsible for phosphorylating the regulatory MLC
(Bresnick, 1999), also affected cadherin-based cell–cell con-
tacts. Immunofluorescent staining revealed that ML-7
(10 M) significantly reduced the intensity of endogenous
E-cadherin staining at contacts between MCF-7 cells (Figure
5A), similar to the effect of blebbistatin. This implied that
activation of Myosin 2 by MLCK was necessary for surface
E-cadherin to concentrate at cell–cell contacts. To test this
notion further we used FRAP analysis to assess the kinetics
of steady-state cadherin accumulation at contacts between
hE-Cad-YFP-CHO cells (Figure 5, B and C, and Table 1).
E-Cad-YFP fluorescence in control cells rapidly recovered
after photobleaching of cell–cell contacts, with 65% recov-
ery achieved within the 20–25-min observation period (Ta-
ble 1). In contrast, E-Cad-YFP fluorescence recovery was
significantly retarded in cells treated with ML-7 (10 M):
only 35% recovery was attained within the 24-min obser-
vation period (Figure 5C). Kinetic modeling revealed an
approximately fivefold decrease in the rate of recovery of
E-Cad-YFP fluorescence at contacts of ML-7-treated cells,
when compared with recovery in control cells (Table 1).
Together, these data provide further evidence that Myosin 2
participated in the preferential accumulation of E-cadherin
at cell–cell contacts.
Myosin 2 Supports Local Accumulation of E-Cadherin as
an Effector of Rho Kinase Signaling
Myosin 2 is a well-documented effector of Rho signaling,
whose influence is mediated by Rho kinase. Both Rho and
Rho kinase activity have been observed to affect cadherin
organization at cell–cell contacts (Fukata and Kaibuchi,
2001; Vaezi et al., 2002), suggesting that the observed impact
of Myosin 2 on local cadherin accumulation might reflect its
role as an effector of Rho kinase. To test this, we first exam-
ined whether inhibiting Rho kinase affected the localization
of Myosin 2 at cell–cell contacts. As shown in Figure 6A,
endogenous Myosin 2A at cadherin-based cell–cell contacts
was clearly reduced in cells acutely treated with Y-27632.
Moreover, whereas activation-specific ppMLC staining was
readily identified at cadherin-based contacts between con-
trol cells, this was largely abolished by Y-27632 (Figure 6B).
Taken with our observation that Rho kinase inhibition in-
hibited the recruitment and activation of Myosin 2 by
E-cadherin homophilic ligation (Figure 2B), this indicated
that Myosin 2 at cell–cell contacts responds to a Rho kinase-
dependent signaling pathway.
If Myosin 2 regulates the local concentration of E-cadherin
as an effector of Rho kinase signaling, we predicted that
inhibition of Rho kinase should mimic the effects of inhibit-
ing Myosin 2. Indeed, the intensity of endogenous E-cad-
herin staining at contacts between MCF-7 cells was signifi-
cantly reduced by Y-27632 (Figure 7A). Similarly, recovery
of E-Cad-YFP fluorescence after photobleaching was re-
duced by Y-27632 to a comparable degree as ML-7 (Figure
7B, Table 1). But despite these changes in local accumulation
of cadherin, Y-27632 did not affect the surface expression of
E-cadherin in MCF-7 cells as measured using surface trypsin
sensitivity assays (Figure 7C). Therefore inhibiting Rho ki-
nase signaling had effects on the surface distribution of
E-cadherin that were identical to those seen when Myosin 2
activity was perturbed.
Myosin 2 Activity Is Necessary for Cadherin Adhesion
and Contact Formation in Response to Homophilic
Ligation
These findings pointed to a positive contribution of Myosin
2 to cadherin-based cell–cell contacts. In contrast, other
studies identified a role for myosin-based contractility in
Figure 5. Myosin light-chain kinase activity is necessary for local
accumulation of E-cadherin at cell–cell contacts. (A) Inhibition of
MLCK affects E-cadherin accumulation at cell–cell contacts. MCF-7
monolayers were incubated with ML-7 (10 M) or vehicle for 60–90
min then processed for E-cadherin immunofluorescence and quan-
titation. One set of cells (Recovery) were treated with drug for 60
min and then allowed to recover in fresh drug-free medium before
fixation. (B) ML-7 affects recovery of E-cadherin-YFP fluorescence
after photobleaching of cell–cell contacts. Contacts between CHO
cells stably expressing E-cadherin-YFP were photobleached, and the
subsequent recovery of cadherin fluorescence was monitored by
time-lapse epi-fluorescence microscopy. Cells were incubated with
ML-7 (10 M) or vehicle alone before experiments. Representative
images from movies are shown; circles mark the photobleached
areas. (C) E-cadherin-YFP fluorescence recovery at cell–cell contacts
after photobleaching was calculated and modeled as detailed in
Materials and Methods.
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disrupting contacts between cancer cells in monolayer cul-
ture (Avizienyte et al., 2004). Those studies, like ours, used
global inhibitors of myosin activity, which carry the poten-
tial interpretive caveat that it is difficult to distinguish the
effects that this ubiquitous motor may have on cadherin
function from those potentially associated with integrin-
based adhesion, transcellular contractility, or trafficking. To
further test the notion that Myosin 2 activity can positively
affect cadherin function, we therefore examined the impact
of perturbing Myosin 2 function in cadherin-specific assays
using planar substrata coated with hE/Fc (Figure 8). This
allowed us to isolate effects on cadherin function indepen-
dent of contractile events linked to cell-matrix adhesion.
As previously described (Kovacs et al., 2002b; Verma et al.,
2004), freshly isolated cadherin-containing cells rapidly
adhered to, and extended broad lamellipodia upon, hE/Fc-
coated substrata (Figure 8B, arrowhead). Formation of lamel-
lipodia in this assay system is inhibited by function-blocking
anti-cadherin antibodies (Kovacs et al., 2002b), indicating that
these are cadherin-dependent lamellipodia. Addition of bleb-
bistatin (10 M), ML-7 (10 M), or Y-27632 (10 M) to freshly
isolated cells at the beginning of the assays significantly de-
Figure 6. Myosin 2 and activated MLC localizes to cell–cell con-
tacts in response to Rho kinase signaling. MCF-7 monolayers were
treated with 10 M Y-27632 for 30 min, fixed, and processed for
immunolocalization of endogenous Myosin 2A and E-cadherin (A)
or ppMLC and E-cadherin (B). Strikingly, Y-27632 treatment re-
duced significantly the accumulation of both Myosin 2 and ppMLC
at cell–cell contacts.
Figure 7. Rho kinase signaling is necessary for the local accumu-
lation of E-cadherin at cell–cell contacts. (A) Accumulation of en-
dogenous E-cadherin at contacts between MCF-7 cells treated with
Y-27632 (10 M) for 0–6 h. E-cadherin accumulation at cell–cell
contacts was measured by quantitative immunofluorescence mi-
croscopy. Data are means  SE. (B) FRAP analysis of E-cadherin-
YFP accumulation at contacts between hE-YFP-CHO cells treated
with either Y-27632 (10 M) or vehicle alone. (C) Surface expression
of E-cadherin in MCF-7 cells treated with Y-27632 (10 M) or vehicle
alone was measured by surface trypsin protection assays (SM, start-
ing material, E, trypsinization in the presence of EGTA). All the
cadherin remained accessible to surface trypsinization in both con-
trol and drug-treated cells. These data were representative of three
independent experiments.
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creased the strength of cadherin adhesion as measured by the
resistance of cells to detachment from hE/Fc-coated substrata
(Figure 8A). This was associated with a marked reduction in
the ability of cells to extend their adhesive contact zones, as
measured by the formation of cadherin-based lamellipodia
(Figure 8B). Together, these data indicated that Myosin 2 ac-
tivity contributes positively to cadherin adhesive function, in-
dependently of other effects that it has in cells.
Myosin 2 Activity Preferentially Supports Actin Bundles
at Cadherin Adhesive Contacts
We then sought further insight into the potential mechanism
by which Myosin 2 might affect the ability of cadherins to
accumulate within adhesive contacts. Because Myosin 2 is
an actin-based motor that mediates cytoskeletal contractility,
we first examined the effect of perturbing Myosin 2 activity
in hE-CHO cells adherent to hE/Fc-coated substrata (Figure
9). Phalloidin staining revealed two patterns of actin orga-
nization in control cells: broad bands of F-actin found at the
outer margins of cadherin-based lamellipodia and promi-
nent bundles that traversed the cells (Figure 9A). Cellular
E-cadherin stained throughout the adhesive interfaces, typ-
ically being found as discontinuous linear streaks at the very
outer margins of cadherin-based lamellipodia and as lateral
clusters of varying size within the contact zones. The lateral
clusters appeared to exist as two qualitatively distinct types:
large streaklike clusters (“macroclusters”) that typically
formed the termini of prominent actin bundles (Figure 9, A
and B, arrowheads) and finer puncta that were often inde-
pendent of actin bundles (Figure 9A). To assess which of
these structures might require Myosin 2, we allowed cells to
first adhere and spread on hE/Fc-coated substrata for 60
min, sufficient for the cells to form cadherin clusters and
their associated F-actin bundles (Figure 9B). Adherent cells
were then treated with blebbistatin, Y-27632, or ML-7 for a
further 30 min before fixation. All drugs largely abolished
both the streaklike macroclusters and the actin bundles as-
sociated with them (Figure 9B), although the F-actin staining
at the leading edges of lamellipodia was preserved.
These observations suggested that Myosin 2 might be
especially necessary to support actin cables that are found at
cadherin adhesive contacts. To pursue this, we then exam-
ined the effect of blebbistatin on F-actin organization at
native cell–cell contacts. Analogous to what we had seen in
hE/Fc adhesion assays, two patterns of F-actin were identi-
fiable at cell–cell contacts in confluent MCF-7 monolayers:
prominent perijunctional actin cables that often terminated
Figure 8. Myosin 2 activity is necessary for cadherin homophilic
adhesion. (A) Inhibition of Myosin 2 activity affects E-cadherin-
mediated adhesion measured by resistance to detachment from
cadherin-coated substrata. hE-CHO cells were plated onto substrata
coated with hE/Fc and allowed to adhere in the presence or absence
of blebbistatin (10 M), Y-27632 (10 M), or ML-7 (10 M) for 90
min. Cells were then detached and residual adherent cells measured
as described in Materials and Methods. The numbers of adherent cells
in drug-treated samples were normalized to controls subjected to
the same experimental manipulations. Experiments were performed
in triplicate on at least three separate occasions. (B) Myosin activity
is necessary for E-cadherin-mediated contact zone extension.
Freshly isolated hE-CHO cells were allowed to adhere to and extend
contacts upon hE/Fc-coated substrata for 90 min in the presence of
blebbistatin (10 M), Y-27632 (10 M), or ML-7 (10 M). The ability
of cells to extend contacts (Lamellipodial Index) was measured on
phalloidin-stained samples as described in Materials and Methods.
Data are means  SE (n  30–35). Insets show representative
images of phalloidin-stained control and blebbistatin-treated cells;
the arrowhead indicates a broad cadherin-based lamella.
Figure 9. Myosin 2 activity supports cadherin-based actin bundles
in homophilic adhesion assays. (A) Two patterns of F-actin organi-
zation are evident in hE-CHO cells adherent to hE/Fc-coated sub-
strata. Cells were allowed to adhere to hE/Fc for 90 min before
fixation and immunostaining for cellular E-cadherin using antibod-
ies directed against the cytoplasmic tail and F-actin (phalloidin).
Phalloidin staining revealed dense bands of F-actin at the outer
margins of cadherin-dependent lamellipodia and also prominent
bundles that typically terminated in large cadherin clusters (mac-
roclusters, arrowheads). (B) Lateral organization of cellular E-cad-
herin and formation of actin bundles at cadherin adhesive interfaces
requires Myosin 2. hE-CHO cells that had adhered to hE/Fc-coated
coverslips for 60 min were then treated with the indicated drugs (all
at 10 M) for a further 30 min. Cadherin macroclusters (arrow-
heads) and the actin bundles they demarcate were largely abolished
in drug-treated cells.
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in puncta of E-cadherin, and finer cortical staining at the
very cadherin adhesions themselves (Figure 10A, arrows).
Both patterns were most readily evident at the very apical
regions of cell–cell contacts. Characteristically, Myosin 2
staining at cell–cell contacts demarcated actin bundles as
well as the more diffuse F-actin staining found immediately
at the cell–cell contacts (unpublished data). Blebbistatin (10
M, 90 min) substantially reduced the perijunctional cables,
but cortical F-actin staining was still detectable at the adhe-
sive contacts (Figure 10B, arrowheads). Similar effects were
seen with Y-27632 and to a lesser extent with ML-7 (unpub-
lished data). Taken together, these observations suggest that
Myosin 2 may preferentially support the actin cables that
form at cadherin adhesive contacts.
DISCUSSION
Classical cadherins do not distribute passively on the cell
surface; instead, they accumulate at cell–cell contacts as a
characteristic response to productive adhesive ligation. Such
focal concentration of cadherin requires that the intrinsic
binding activity of the cadherin ectodomain be functionally
linked to essential cytoplasmic determinants, whose nature
is incompletely understood. Our current data now identify
Myosin 2 as a critical regulator of cadherin accumulation
that is coupled to homophilic adhesive ligation through a
Rho kinase signaling pathway. Myosin 2 is thus centrally
placed to mediate the contributions of cell signaling and the
actin cytoskeleton previously implicated in supporting cad-
herin accumulation at cell–cell contacts.
Myosin 2 Is Necessary for E-Cadherin to Accumulate at
Cell–Cell Contacts
We found that the ability of cells to concentrate cadherins at
cell–cell contacts was consistently impaired when Myosin 2
activity was either inhibited directly with blebbistatin, or
indirectly, by using ML-7 to block MLCK, which is imme-
diately responsible for phosphorylating MLC. Instead of
staining as intense bands confined to the apical regions of
MCF-7 cell–cell contacts, E-cadherin expression at contacts
was reduced in cells treated with either drug, often being
replaced by more diffuse punctate staining when contacts
were viewed en face. Similarly, in live cell imaging studies
the intensity of E-Cad-YFP accumulation at contacts was
significantly reduced by blebbistatin. Characteristically this
occurred within 30–60 min of treatment with drugs, sug-
gesting that ongoing Myosin 2 activity is necessary to main-
tain cadherins at cell–cell contacts. Similar effects on endog-
enous E-cadherin were also seen in cells expressing a
dominant negative Myosin 2 mutant (unpublished data).
These findings are consistent with the recent report that
embryos lacking Myosin 2A showed an adhesive defect
accompanied by a loss of cadherin concentration at cell–cell
contacts (Conti et al., 2004).
Furthermore we found that ML-7 reduced significantly
the rate at which E-cadherin-YFP fluorescence recovered at
cell–cell contacts after photobleaching. Note that in these
experiments we used FRAP as an independent kinetic index
of local cadherin accumulation, rather than to measure the
diffusional properties of the cadherin. We reasoned that
when cells are at steady state, differences in the rates of
E-Cad-YFP fluorescence recovery would reflect differences
in the ability of cadherin to preferentially accumulate at the
contacts. The reduced fluorescence recovery that we ob-
served might be due to changes in either the surface move-
ment of cadherin into the photobleached contact area
and/or in its retention there. Irrespective of the precise
mechanism, the impaired recovery of E-cadherin-YFP fluo-
rescence implies a defect in the capacity of cells to locally
accumulate cadherin at contacts. Thus, measured by two
independent assays, our data indicate that Myosin 2 activity
is necessary for E-cadherin to locally accumulate at cell–cell
contacts.
Formally, the ability of cells to concentrate cadherins at
contacts might reflect traffic of cadherins between the
plasma membrane and the cytoplasm and/or mechanisms
that control the regional distribution of cadherins once it is
at the cell surface. Myosin 2 is certainly implicated in a range
of cell trafficking pathways that potentially affect cadherin
expression (Stow et al., 1998; Togo and Steinhardt, 2004).
These include a role in supporting E-cadherin endocytosis
when cell–cell contacts are broken or being remodeled
(Ivanov et al., 2004). Directed transport of cadherins to cell–
cell contacts has also been reported in some (Mary et al.,
2002; Chen et al., 2003), but not all, studies (Adams et al.,
1998), and Myosin 2 participates in several steps during
Figure 10. Blebbistatin perturbs perijunc-
tional actin cables. Confluent MCF-7 mono-
layers were stained for E-cadherin or F-actin
as indicated. In control cells F-actin was
found in prominent perijunctional actin ca-
bles (arrowheads) as well as in fine cortical
bands (arrows) that localized with E-cad-
herin itself (arrows). Blebbistatin (10 M, 90
min) abolished many of the perijunctional
actin bundles, but residual cortical F-actin
staining was evident at the cell–cell contacts
(arrows).
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exocytic transport (Stow et al., 1998), although whether this
affects cadherin transport has not yet been tested. However,
if Myosin 2 were principally determining the local accumu-
lation of E-cadherin through cadherin trafficking, then we
would predict that inhibiting Myosin 2 should affect the
surface expression of E-cadherin. Specifically, inhibition of
E-cadherin endocytosis should increase E-cadherin levels at
the cell surface, whereas disruption of exocytosis would
reduce surface cadherin expression. However, we detected
no changes in surface E-cadherin expression, by either tryp-
sin-sensitivity or surface biotinylation assays (unpublished
data), under conditions where local concentration of cad-
herin at contacts was substantially reduced. These data sug-
gest instead that surface cadherins redistribute away from
cell–cell contacts as the dominant early consequence of in-
hibiting Myosin 2. Thus, although we cannot exclude subtle
effects on cadherin trafficking, our data indicate that Myosin
2 exerts a major influence to control the regional localization
and accumulation of E-cadherin when it is at the cell surface.
Myosin 2 Is an Effector of Rho Kinase Signaling at
Cadherin Contacts
The effect of Myosin 2 inhibition that we observed resem-
bled closely the rapid loss of E-cadherin from cell–cell con-
tacts that occurs in a variety of cell types when Rho is
inhibited (Braga et al., 1997, 2000; Takaishi et al., 1997;
Charrasse et al., 2002). Although it has been recognized for
several years that Rho signaling can critically support cad-
herin-based cell–cell contacts (Fukata and Kaibuchi, 2001),
the molecular targets responsible for this activity have re-
mained obscure. Of note, though, Myosin 2 is a major effec-
tor for Rho signaling in cells. Rho acts through Rho kinase,
which stimulates Myosin 2 by inhibiting myosin phospha-
tase and possibly also by phosphorylating MLC itself
(Amano et al., 1996; Kimura et al., 1996). The final outcome is
activation of myosin binding to actin filaments after the
phosphorylation of the regulatory myosin light chain.
Three lines of data indicate that this canonical Rho kinase
pathway determined the ability of Myosin 2 to support local
concentration of cadherins in our experiments. First, inhibi-
tion of Rho kinase signaling blocked the recruitment of
Myosin 2 both to cadherin-based cell–cell contacts and to
sites of homophilic E-cadherin adhesion. Second, activation
of Myosin 2 at cadherin contacts was sensitive to Rho kinase
signaling. Treatment of cells with Y-27632, a reasonably
specific and widely used inhibitor of Rho kinase activity
(Uehata et al., 1997), blocked both the phosphorylation of
MLC in response to homophilic ligation and the accumula-
tion of ppMLC at cell–cell contacts. Finally, inhibition of
Rho kinase signaling produced functional effects very simi-
lar to those seen with Myosin 2 inhibitors, including reduced
accumulation of cadherin at cell–cell contacts (measured
with quantitative IF and FRAP) and reduced adhesion to
cadherin-coated substrata. Taken together, these findings
suggest strongly that Myosin 2 mediates the effect of Rho
signaling to concentrate cadherins locally at cell–cell con-
tacts.
Furthermore, our data indicate that Rho kinase cooperates
with an instructive effect of cadherin homophilic ligation
itself to recruit and activate Myosin 2 at cadherin adhesive
contacts. Thus, not only was E-cadherin adhesion necessary
for Myosin 2 to localize at cell–cell contacts, but homophilic
adhesion induced using recombinant cadherin ligands was
sufficient to recruit and activate Myosin 2. However, recruit-
ment of Myosin 2 by homophilic adhesion also required Rho
kinase. One possibility is that Myosin 2 is recruited as an
early response to cadherin-activated Rho signaling itself,
which has been observed in some (Charrasse et al., 2002), but
not all studies (Noren et al., 2001). Alternatively, cadherin
homophilic ligation may cooperate with other cell signaling
pathways that stimulate Rho kinase activity.
Irrespective of the precise molecular mechanism, Myosin
2 appears then to be one of a range of actin-regulatory
proteins that can be rapidly recruited to cadherin contacts in
response to homophilic ligation alone. In this case, we sug-
gest that Myosin 2 acts as part of a positive feedback path-
way that stabilizes the surface localization of cadherins fol-
lowing homophilic ligation. We envisage that the
recruitment of Myosin 2 in response to cadherin homophilic
ligation would support the local accumulation of cadherin,
ultimately leading to cohesive adhesion. Myosin 2 would
then play a key role in the stabilization of nascent cell–cell
contacts and in maintaining established contacts.
Myosin 2 Exerts a Positive Influence on Cadherin
Function
How then might Myosin 2 affect the surface distribution of
cadherins? One mechanism might be through lateral clus-
tering, which occurs in response to homophilic cadherin
ligation (Yap et al., 1997). When cells adhere to cadherin-
coated substrata, we characteristically observe two distinct
patterns of cadherin clusters, fine puncta, and larger streak-
like macroclusters, that resemble the distinction between
local contacts and focal adhesions seen at integrin adhesions.
Strikingly, inhibition of Myosin 2 activity appeared to pref-
erentially abolish the macrocluster pool, suggesting that My-
osin 2 participated in the generation of these larger cadherin
clusters. Interestingly, those cadherin macroclusters typi-
cally formed the termini for prominent actin bundles, which
were also reduced substantially when Myosin 2 activity was
blocked, both in planar adhesion assays and at native cell–
cell contacts. Myosin 2 has commonly been implicated in
generating actin bundles, consistent with its role as an actin-
based motor. It is therefore tempting to postulate that My-
osin 2-based contractility may support large cadherin clus-
ters by bundling associated actin filaments, analogous to the
mechanism by which actin stress fibers may support inte-
grin-based focal adhesions (Chrzanowska-Wodnicka and
Burridge, 1996).
It is important to note that whereas our data imply a
positive contribution of Myosin 2 to cadherin function, other
studies have implicated Myosin 2 in processes that nega-
tively affect cadherin activity (Avizienyte et al., 2004). The
latter include contractile events activated by Rho kinase that
disrupt cell–cell contacts (Sahai and Marshall, 2002) and also
the endocytosis of E-cadherin after contacts are broken
(Ivanov et al., 2004). The apparent discrepancies between our
results and those of earlier studies may reflect differences in
cell types, growth conditions, and in the assays used to
perturb and measure cadherin activity. Moreover, it is per-
haps not surprising that this ubiquitous motor participates
in a range of cellular processes that directly or indirectly
affect E-cadherin. For example, contractile events elsewhere
in the cell may affect the integrity of cell–cell contacts if they
are mechanically coupled. Thus, the balance between Myo-
sin 2 activities in different regions of the cell is likely to
critically determine the functional consequences of Myosin 2
inhibition. All current maneuvers to perturb Myosin 2 ac-
tivity are predicted, however, to act globally within cells,
rather than selectively ablating its activity in specific subcel-
lular pools or regions. In this regard, it is interesting to note
that the integrity of cell–cell contacts was not disrupted
when monolayers were treated with drugs for up to 6 h
(unpublished data). It is possible that the residual cadherin
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found at cell–cell contacts was sufficient to maintain cohe-
sion. Alternatively, global inhibition of Myosin 2 activity is
likely to have also blocked the contractile forces that tend to
disrupt contacts by pulling cells apart from one another.
Nonetheless, our studies using hE/Fc-based adhesion as-
says confirm that Myosin 2 contributes positively to cad-
herin function when it is examined in isolation from other
adhesive or transcellular interactions that occur when cells
grow as confluent sheets. Thus, we found that inhibition of
Myosin 2 activity reduced both cell adhesion and the capac-
ity of cells to extend adhesive contacts upon attachment to
cadherin-coated substrata. Indeed, changes in clustering and
macroscopic concentration of cadherins, both of which can
increase adhesive strength, might account for this positive
contribution to adhesion. Taken with our other data, we
therefore conclude that Myosin 2 can contribute positively to
cadherin function, consistent with observations made in My-
osin 2A-deficient mouse embryos (Conti et al., 2004). This
emphasizes that, ultimately, the overall contribution of my-
osin activity to epithelial morphology and organization is
likely to reflect the balance between this positive effect on
cadherin function and local concentration and the actions of
other pools of myosin elsewhere in the cell.
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